{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:10:15Z","timestamp":1756289415841,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,7,24]]},"abstract":"<jats:p>We describe a case of a man with chronic myeloid leukaemia who achieved remission through dasatinib therapy after being unable to tolerate several tyrosine kinase inhibitor (TKI) regimens due to severe physical side effects. However, this coincided with the onset of distressing agitation, insomnia and motor restlessness leading him to take a large zopiclone overdose. Start of appropriate therapy with a clonazepam, venlafaxine and mirtazapine combination led to a rapid improvement in symptomatology. We discuss the differential diagnosis and review the literature of neuropsychiatric complications of TKIs. This case serves as an illustrative reminder that in cases of complicated agitation referral to specialist mental health teams for rational psychopharmacological management is advised.<\/jats:p>","DOI":"10.1136\/bcr-2014-204166","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T06:24:58Z","timestamp":1407824698000},"page":"bcr2014204166","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Severe agitation in depression precipitated by dasatinib"],"prefix":"10.1136","volume":"2014","author":[{"given":"Musa Basseer","family":"Sami","sequence":"first","affiliation":[{"name":"Epsom Community Mental Health Recovery Service, Surrey & Borders NHS Partnership Foundation Trust, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida","family":"Yousaf","sequence":"additional","affiliation":[{"name":"Mole Valley CMHRS, Surrey & Borders NHS Partnership Foundation Trust, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fialho","sequence":"additional","affiliation":[{"name":"Epsom Community Mental Health Recovery Service, Surrey & Borders NHS Partnership Foundation Trust, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.38"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.2","unstructured":"Food and Drug Administration. Sprycel (Dasatnib) Efficacy Supplement with Clinical Data to Support. 2007. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2007\/021986_s001_s002.pdf (accessed 18 Jan 2014)."},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.3","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07071150"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1630-5"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7236"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.7","unstructured":"NICE. Depression: the treatment and management of depression in adults (update). NICE clinical guideline 90 . 2009. http:\/\/www.nice.org.uk\/CG90 (accessed 29 Mar 2014)."},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.8","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.1.1.59.52296"},{"key":"2025082702294778000_2014.aug12_1.bcr2014204166.9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107065738"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2014-204166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:29:59Z","timestamp":1756286999000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2014-204166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":9,"alternative-id":["10.1136\/bcr-2014-204166"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2014-204166","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2014,8,12]]}}}